Memory loss in Relafen - how severe and when it was recovered? (a real world drug study)

Summary:

We study how severe was Memory loss, when it was recovered, drug effectiveness, race, and more among people who take Relafen (nabumetone). This phase IV clinical study is created by eHealthMe based on reports submitted to eHealthMe, and is updated regularly.

What is Relafen?

Relafen has active ingredients of nabumetone. It is often used in arthritis. eHealthMe is studying from 6,243 Relafen users. Check the latest studies of Relafen.

What is Memory loss?

Memory loss is found to be associated with 2,727 drugs and 4,377 conditions by eHealthMe. Check the latest studies of Memory loss.

On Jun, 19, 2026

2 people who have Memory loss while taking Relafen were studied.

Severity of Memory loss *:

least: 0.0 %
moderate: 0.0 %
severe: 100 %
most severe: 0.0 %

When people recovered from Memory loss:

n/a

Effectiveness of Relafen *:

not at all: 0.0 %
somewhat: 100 %
moderate: 0.0 %
high: 0.0 %
very high: 0.0 %

Race of the people *:

African American, Non-Hispanic: 0.0 %
American Indian/Alaska Native: 0.0 %
Asian: 0.0 %
Hispanic: 0.0 %
Native Hawaiians/Pacific Islanders: 0.0 %
Two or more races: 0.0 %
White, Non-Hispanic: 100 %

Time on Relafen *:

Gender of people when taking Relafen *:

female: 100 %
male: 0.0 %

Age of people when taking Relafen *:

Conditions people have *:

High Blood Pressure: 2 people, 100.00%
Neuralgia (pain in one or more nerves): 1 person, 50.00%
Muscle Spasms (muscle contraction): 1 person, 50.00%
Hypomagnesemia (electrolyte disturbance in which there is an abnormally low level of magnesium in the blood): 1 person, 50.00%
Hypokalemia (low potassium): 1 person, 50.00%
High Blood Cholesterol: 1 person, 50.00%
Fibromyalgia (a long-term condition which causes pain all over the body): 1 person, 50.00%
Depression Suicidal (suicide depressive disorder): 1 person, 50.00%
Depression: 1 person, 50.00%
Attention Deficit Hyperactivity Disorder (a chronic condition including attention difficulty, hyperactivity, and impulsiveness): 1 person, 50.00%

Other drugs people take besides Relafen *:

Vitamin D: 1 person, 50.00%
Vitamin B12: 1 person, 50.00%
Chondroitin And Glucosamine: 1 person, 50.00%
Coq10: 1 person, 50.00%
Flexeril: 1 person, 50.00%
Fluoxetine Hydrochloride: 1 person, 50.00%
Klor-Con M10: 1 person, 50.00%
Lexapro: 1 person, 50.00%
Lisinopril: 1 person, 50.00%
Magnesium: 1 person, 50.00%

Other side effects people have besides Memory loss *:

Weight Loss: 1 person, 50.00%
Vision Blurred: 1 person, 50.00%
Speech Impairment (Adult) (inability to speak (adult)): 1 person, 50.00%
Hyperhidrosis (abnormally increased sweating): 1 person, 50.00%
Hand Tremor: 1 person, 50.00%
Dry Mouth: 1 person, 50.00%
Drowsiness: 1 person, 50.00%
Dizziness: 1 person, 50.00%
Crying: 1 person, 50.00%

* Approximation only. Some reports may have incomplete information.

Do you take Relafen and have Memory loss?

Check whether Memory loss is associated with a drug or a condition

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Related studies

Memory loss in Relafen

How the study uses the data?

The study is based on nabumetone (the active ingredients of Relafen). Other drugs that have the same active ingredients (e.g. generic drugs) are considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.